PharVision Advisers’s Eve Holding EVEX Stock Holding History

PharVision Advisers’s Portfolio EVEX Stock Details EVEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-47,794	Closed	-$191K	–	279
2025 Q4	$191K	Buy	+47,794	New	+$210K	0.1%	578

Other funds holding EVEX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BGDI

BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return

UAH

United Airlines Holdings Chicago, Illinois $211M AUM

SGDR

SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return

PharVision Advisers's EVEX Position: Q1 2026 in Review

PharVision Advisers sold out of Eve Holding (EVEX) in Q1 2026, closing a stake of 47,794 shares — an estimated $191K sold.

PharVision Advisers first reported a position in EVEX in Q4 2025 and held it in 1 quarter. The position peaked at $191K in Q4 2025. 142 funds tracked by Wall St. Rank hold EVEX as of Q1 2026.

PharVision Advisers reported no remaining Eve Holding position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 47,794 Eve Holding shares in Q1 2026, an estimated $191K.
PharVision Advisers first reported a position in Eve Holding in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Eve Holding position peaked at $191K in Q4 2025.
142 funds tracked by Wall St. Rank held Eve Holding as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.